News

Oil- and nut-supplemented Mediterranean diet improves elderly cognition


 

References

A Mediterranean diet supplemented by nuts or olive oil was associated with improved cognitive function in people aged 55-80 years, according to Cinta Valls-Pedret of the Institut d’Investigacions Biomèdiques August Pi Sunyer, Hospital Clínic, Barcelona, Spain, and associates.

Study participants on the Mediterranean diet plus olive oil scored significantly higher on the Rey Auditory Verbal Learning Test and the Color Trail Test part 2, compared with the control group on Mediterranean diet alone. Participants on the nuts and olive oil Mediterranean diet either kept their memory composite, frontal cognition composite, and global cognition composite scores close to the baseline or increased them slightly, while those on the control diet saw significantly decreased scores in all areas.

“The beneficial effect of Mediterranean diets on cognition probably stems from the abundance of antioxidants and anti-inflammatory agents that they provide. The supplemental foods, extra virgin olive oil and nuts, are particularly rich in phenolic compounds that might counteract oxidative processes in the brain, leading to neurodegeneration,” the authors noted.

Find the full study in JAMA Internal Medicine (2015 May 11 [doi:10.1001/jamainternmed.2015.1668]).

Recommended Reading

Blocking breakdown of arginine may prevent AD
MDedge Neurology
Memantine plus cholinesterase inhibitor improves behavioral symptoms in Alzheimer’s
MDedge Neurology
Study aims to bolster argument for reimbursing amyloid imaging
MDedge Neurology
Novel oral anticoagulants best warfarin for AF in heart failure
MDedge Neurology
VIDEO: Expert picks top studies in Alzheimer’s, migraine, and stroke at AAN
MDedge Neurology
AAN: Cleveland mobile stroke unit reduces time to thrombolysis
MDedge Neurology
VIDEO: Consider adult ADHD in dementia differential diagnosis
MDedge Neurology
AAN: OnabotulinumtoxinA injections reduce migraine hospitalizations
MDedge Neurology
AAGP: Treating Parkinson’s psychosis takes balance on risk/benefit tightrope
MDedge Neurology
AAN: Largest neuroleptic malignant syndrome study finds predictors of poor outcome
MDedge Neurology